Abstract Background: Baseline prognostic biomarkers stratifying treatment strategies in first-line metastatic...
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Journal name :
BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...
Posted by : Pr. Franck BONNETAIN, , Dr. Sophie PAGET-BAILLY
Journal name : PlosOne
AbstractOverall survival (OS) has been considered as the most relevant primary endpoint but trials using OS often...
Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY
Journal name : Expert Review of Anticancer Therapy